⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

ITGR

Integer Holdings Corporation

Healthcare · Medical Devices

125.86USD

-0.3400 (-0.27%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗

Estimates and surprises

Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.

PeriodConsensus EPS90 days agoRevisions up (30d)Revisions down (30d)
Current quarter$1.68▼$1.6921
Next quarter$1.79▼$1.812
Current year$6.16▲$6.0830
Next year$6.87▲$6.8111

Recent quarters

Beat in 4 of the last 4

QuarterEstimateActualSurprise
2026-06-30$1.38$1.6+0.22 (+15.8%)
2026-03-31$1.19$1.2+0.01 (+1.1%)
2025-12-31$1.7$1.76+0.06 (+3.6%)
2025-09-30$1.68$1.79+0.11 (+6.8%)

Wall Street coverage

96 ratings from 15 firms

Ratings are attributed to the research firm, not to individual analysts. See every ticker.

FirmActionRatingPrice TargetDate
BenchmarkDowngraded from BuyHold—Aug 14, 2026
OppenheimerDowngraded from OutperformPerform—Aug 4, 2026
Truist SecuritiesDowngraded from BuyHold$110 $127Aug 4, 2026
Wells FargoMaintainedEqual-Weight$84 $127Aug 4, 2026
Freedom Capital MarketsDowngraded from BuyHold—Aug 4, 2026
KeybancDowngraded from OverweightSector Weight—Aug 3, 2026
Freedom Capital MarketsInitiatedBuy$112Jul 22, 2026
Truist SecuritiesMaintainedBuy$97 $110Jul 16, 2026
CitigroupMaintainedNeutral$92 $96Jul 8, 2026
CitigroupMaintainedNeutral$89 $92May 28, 2026
OppenheimerUpgraded from PerformOutperform$115May 13, 2026
CitigroupMaintainedNeutral$92 $89May 1, 2026
Piper SandlerReiteratedOverweight$87 $97May 1, 2026
CitigroupMaintainedNeutral$75 $92Feb 20, 2026
Wells FargoMaintainedEqual-Weight$72 $84Feb 20, 2026
BenchmarkUpgraded from HoldBuy$95Feb 20, 2026
Truist SecuritiesMaintainedBuy$95 $97Feb 20, 2026
Truist SecuritiesMaintainedBuy$86 $95Dec 18, 2025
CitigroupMaintainedNeutral$69 $75Dec 11, 2025
Truist SecuritiesMaintainedBuy$88 $86Nov 24, 2025
CitigroupMaintainedNeutral$77 $69Nov 3, 2025
Truist SecuritiesMaintainedBuy$121 $88Oct 24, 2025
Raymond JamesReiteratedOutperform$143 $95Oct 24, 2025
Piper SandlerMaintainedOverweight$155 $82Oct 24, 2025
BenchmarkDowngraded from BuyHold—Oct 24, 2025

Insider transactions

77 filings from 23 insiders · 16 buy / 1 sell over 6m

Officers and directors of ITGR, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.

InsiderActionSharesPriceValueDate
THOR KIRK KOfficerOther6.1k——Jun 30, 2026
COYLE MICHAEL JDirectorGrant2.0k——May 20, 2026
MAXWELL MARTIN CRAIGDirectorGrant2.0k——May 20, 2026
PASSERINI FILIPPODirectorGrant2.0k——May 20, 2026
JEFFERS ALVIN TYRONEDirectorGrant2.0k——May 20, 2026
ANTRUM SHEILADirectorGrant2.0k——May 20, 2026
CAPPS CHERYL CDirectorGrant2.0k——May 20, 2026
KAPITO AARON J.DirectorGrant2.0k——May 20, 2026
FLANAGAN JAMES FRANCISDirectorGrant2.0k——May 20, 2026
STEPHENS JIMOfficerOther2.0k——May 15, 2026
SMITH DIRONChief Financial OfficerOther2.1k——May 8, 2026
HARRIS JOHN AOfficerOther3.8k——Mar 31, 2026
BLACKWOOD LINDSAY K.General CounselOther3.5k——Mar 24, 2026
CARR TERENCEOfficerOther1.4k——Mar 24, 2026
THOMAS TOMMY P.OfficerSell825$85.00$70kMar 13, 2026
KAPITO AARON J.DirectorGrant410——Mar 12, 2026
FLANAGAN JAMES FRANCISDirectorGrant410——Mar 12, 2026
KHALES PAYMANChief Executive OfficerOther43.1k——Feb 24, 2026
THOR KIRK KOfficerGrant9.0k——Feb 20, 2026
THOMAS TOMMY P.OfficerGrant1.9k——Feb 20, 2026

Analyst Notes

Sign in to write

No analyst notes on ITGR yet.

Analyst Ratings

5 analysts covering

PeriodStrong BuyBuyHoldSellStrong SellConsensus
Current00900Hold3.00
1 mo ago25400Buy2.18
Price target$121.80$101.00 – $127.00
-3.2% to target